Atlas Trials

Safety and Efficacy Assessments of Osalmid in Multiple Myeloma

Clinical trial NCT03670173 · UNKNOWN

Trial details

NCT number
NCT03670173
Sponsor
Shanghai 10th People's Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2018-10-01
Primary completion
2021-05-18
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.